Can Septrin (co‑trimoxazole) double‑strength be given with linezolid, and what infections does this combination cover?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Septrin Double Strength Be Given With Linezolid?

Yes, Septrin (co-trimoxazole) double strength can be combined with linezolid, and this combination is specifically used to provide broad-spectrum coverage for MRSA plus additional gram-negative and atypical organisms in serious infections.

What This Combination Covers

This dual-antibiotic regimen targets:

  • MRSA (Methicillin-Resistant Staphylococcus aureus) - covered by linezolid
  • Additional gram-positive organisms - covered by both agents
  • Gram-negative bacteria - covered by co-trimoxazole (linezolid has NO gram-negative activity)
  • Pneumocystis jirovecii - covered by co-trimoxazole
  • Other organisms: Nocardia, Listeria, Stenotrophomonas, Toxoplasma - covered by co-trimoxazole

Clinical Scenarios Where This Combination Is Used

1. MRSA Bone and Joint Infections

The IDSA MRSA guidelines explicitly recommend TMP-SMX (co-trimoxazole) 3.5-4.0 mg/kg/dose every 8-12 hours as an option for osteomyelitis and septic arthritis 1. When combined with linezolid, you achieve:

  • Enhanced MRSA coverage
  • Broader spectrum for polymicrobial bone infections
  • Oral step-down option for prolonged therapy

2. MRSA Central Nervous System Infections

For meningitis, brain abscess, or epidural abscess, the guidelines list TMP-SMX 5 mg/kg/dose every 8-12 hours as an alternative agent 1. Combining with linezolid (which has excellent CNS penetration) provides:

  • Dual MRSA coverage
  • Linezolid's superior CSF penetration
  • Co-trimoxazole's additional spectrum

3. Polymicrobial Diabetic Foot Infections

The diabetic foot infection guidelines note that narrow-spectrum agents like linezolid should be combined with other agents (e.g., a fluoroquinolone) if polymicrobial infection is suspected 2. Co-trimoxazole serves this role by adding gram-negative coverage that linezolid completely lacks.

4. Severe Skin and Soft Tissue Infections

For necrotizing fasciitis or complicated SSTIs requiring MRSA coverage plus broader spectrum, combining linezolid with co-trimoxazole addresses:

  • MRSA and other gram-positives (linezolid)
  • Potential gram-negative co-pathogens (co-trimoxazole)
  • This is particularly relevant when cultures are pending 3

Critical Safety Considerations

Serotonin Syndrome Risk - MAJOR CONCERN

Both linezolid and co-trimoxazole have weak MAOI properties. The FDA label warns about serotonin syndrome when linezolid is combined with serotonergic agents 4. While co-trimoxazole is not typically listed as a major serotonergic drug, monitor closely for:

  • Confusion, agitation, restlessness
  • Tremors, muscle rigidity
  • Hyperthermia, diaphoresis
  • Autonomic instability

Avoid other serotonergic medications (SSRIs, SNRIs, TCAs, MAOIs) when using this combination.

Myelosuppression - Monitor Weekly

Linezolid causes dose-dependent bone marrow suppression 4. Co-trimoxazole also causes myelosuppression. When combined:

  • Obtain baseline CBC
  • Monitor CBC weekly (mandatory for linezolid >2 weeks)
  • Watch for anemia, thrombocytopenia, leukopenia
  • Consider discontinuation if worsening cytopenias develop

Duration Limitations

  • Linezolid should generally be limited to ≤28 days due to toxicity risk
  • For longer courses, consider transitioning to co-trimoxazole monotherapy if appropriate based on cultures

Gram-Negative Coverage Gap

Critical pitfall: Linezolid has ZERO gram-negative activity 4. The FDA label explicitly states: "Linezolid has no clinical activity against Gram-negative pathogens and is not indicated for the treatment of Gram-negative infections. It is critical that specific Gram-negative therapy be initiated immediately if a concomitant Gram-negative pathogen is documented or suspected" 4.

This is why co-trimoxazole is valuable in this combination - it fills the gram-negative gap.

Dosing Recommendations

Linezolid: 600 mg PO/IV every 12 hours 1

Co-trimoxazole (Septrin DS):

  • For bone/joint infections: 3.5-4.0 mg/kg/dose (based on TMP component) every 8-12 hours 1
  • For CNS infections: 5 mg/kg/dose every 8-12 hours 1
  • For an 80-kg adult: 2 DS tablets (each DS = 160 mg TMP) achieves approximately 4 mg/kg 1

When NOT to Use This Combination

  1. Confirmed gram-positive-only infection - linezolid alone is sufficient
  2. Renal insufficiency - both drugs require dose adjustment; co-trimoxazole is contraindicated in severe renal failure
  3. Baseline cytopenias - additive myelosuppression risk
  4. Patients on serotonergic medications - increased serotonin syndrome risk
  5. Sulfa allergy - absolute contraindication to co-trimoxazole

Alternative Combinations

If you need MRSA coverage plus gram-negative activity but want to avoid this combination:

  • Linezolid + fluoroquinolone (levofloxacin or moxifloxacin) 2
  • Vancomycin + co-trimoxazole
  • Daptomycin + co-trimoxazole (not for pneumonia - daptomycin inactivated by surfactant)

Related Questions

What is the role of Linezolid (oxazolidinone antibiotic) in the treatment of cellulitis?
Which infections can be treated with cotrimoxazole (trimethoprim‑sulfamethoxazole)?
In a patient with a superficial abdominal skin abscess where both methicillin‑resistant Staphylococcus aureus (MRSA) and non‑tuberculous mycobacteria are possible, can linezolid be used as monotherapy while awaiting culture results?
Is cotrimoxazole (trimethoprim‑sulfamethoxazole) the same as trimethoprim?
In an adult with an uncomplicated skin or wound infection and no known drug allergies, how does the antimicrobial coverage of trimethoprim‑sulfamethoxazole (Bactrim) compare to doxycycline?
Can lithium be used with lisinopril, and how should it be monitored?
In a patient with a low‑titer antinuclear antibody (ANA) of 1:80 showing a nucleolar pattern, a negative systemic autoimmune panel, elevated C‑reactive protein (CRP) of 18 mg/L, normal erythrocyte sedimentation rate (ESR), intermittent fatigue, nausea, blurry vision, headache, and metabolic syndrome, what is the clinical significance and what further evaluation and management are recommended?
What is the recommended management for a patient with triglycerides of 405 mg/dL?
What tests should be performed to determine whether a silver‑alginate dressing is retained in a wound?
Why does long‑term duloxetine (Cymbalta) therapy cause increasing anger, irritability, aggression, and heightened reactivity?
Can clopidogrel (Plavix) be used in a patient with brain metastases?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.